Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Error message
No active batch.
Most Viewed
Cost-sharing and initiation of disease-modifying therapy for multiple sclerosis.
MSQoL-54 predicts change in fatigue after inpatient rehabilitation for people with multiple sclerosis.
Fingolimod therapy modulates circulating B cell composition, increases B regulatory subsets and production of IL-10 and TGFβ in patients with Multiple Sclerosis.
Fingolimod (FTY720) therapy in Japanese patients with relapsing multiple sclerosis over 12 months: results of a phase 2 observational extension.
Changes in Fatigue and Cognition in Patients with Relapsing Forms of Multiple Sclerosis Treated with Natalizumab: The ENER-G Study.
Potentiation of High Voltage-Activated Calcium Channels by 4-Aminopyridine Depends upon Subunit Composition.
The gut microbiome in multiple sclerosis.
Geographical Variations in Sex Ratio Trends over Time in Multiple Sclerosis.
Adult mesenchymal stem cell therapy for myelin repair in Multiple Sclerosis.
Role of Platelets in Neurodegenerative Diseases: A Universal Pathophysiology.
The Alice in Wonderland syndrome: an unusual in acute disseminated encephalomyelitis.
A pilot study of the immunological effects of high-dose vitamin D in healthy volunteers.
Mechanisms in the Development of Multiple Sclerosis Lesions: Reconciling Autoimmune and Neurodegenerative Factors.
[The use of modern neuroimaging methods in studies of mechanisms of development cognitive disturbances in patients with multiple sclerosis].
A review of the sheep-multiple sclerosis connection.
Magnetic Resonance Imaging in Balo's Concentric Sclerosis. A Case Report.
The role of microglial activation in disease progression.
Glycoengineering of Interferon-β 1a Improves Its Biophysical and Pharmacokinetic Properties.
Cannabinoids control spasticity and tremor in a multiple sclerosis model.
Plasmacytoid dendritic cells and immunotherapy in multiple sclerosis.
Dynamics of saccade parameters in multiple sclerosis patients with fatigue.
Multifocal visual evoked potentials are influenced by variable contrast stimulation in MS.
Compressive syndrome of internal jugular veins in multiple sclerosis: does it matter?
Vitamin d and multiple sclerosis.
[Recurring neuromyelitis without optic neuritis: a case report].
Pages
« first
‹ previous
…
211
212
213
214
215
216
217
218
219
…
next ›
last »